CBI 8th Annual Pharmaceutical Compliance Congress
Cosponsored by Epstein Becker Green
On Monday, January 24, Wendy C. Goldstein, Member of the Firm and Chair of the Health Care and Life Sciences practice, and Sarah K. diFrancesca (Giesting), Associate, will lead a Break Out session titled "Analysis of PPACA - The Implications of Healthcare Reform on Compliance Teams."
Also on Monday, Lynn Shapiro Snyder, Member of the Firm, will moderate a Keynote Industry Panel Discussion titled "Key Insights and Lessons Learned Operating Under a Corporate Integrity Agreement (CIA)."
Registration types are Standard: $2,495; Advantage: $ 2,095; Academic/Govt: $1,295.